2025-04-13 - Analysis Report
## Air Products and Chemicals Inc. (APD) Stock Review

**0. Key Figures:**

* **Cumulative Return (APD):** 26.37%
* **Cumulative Return (VOO):** 66.36%
* **Return Difference (APD vs VOO):** -39.99%
* **Relative Divergence:** 22.7% (This indicates APD's performance relative to VOO is in the 22.7th percentile of its historical range of divergence.)


**1. Company Overview & Performance Comparison:**

Air Products and Chemicals Inc. is a leading industrial gases company.  Over the period analyzed, APD significantly underperformed the S&P 500 (VOO), lagging by approximately 40 percentage points. While APD has exhibited periods of strong growth (e.g., 2017-2019 CAGR of 50%), the recent performance has been negative, potentially explained by factors revealed in the subsequent analysis.  The provided Alpha and Beta data reveals varying levels of outperformance (Alpha) and market sensitivity (Beta) over different timeframes, highlighting the importance of considering the investment timeframe.


**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 23.0% | 53.7% | -6.0% | 0.1 | 30.7 |
| 2016-2018  | 22.0% | 62.1% | 5.0% | 0.4 | 30.7 |
| 2017-2019  | 50.0% | 62.1% | 21.0% | 0.8 | 46.1 |
| 2018-2020  | 36.0% | 62.1% | 10.0% | 0.6 | 54.8 |
| 2019-2021  | 59.0% | 59.2% | 5.0% | 0.6 | 62.3 |
| 2020-2022  | 22.0% | 71.4% | 16.0% | 0.6 | 64.8 |
| 2021-2023  | -18.0% | 71.4% | 0.8 | 0.8 | 59.0 |
| 2022-2024  | -26.0% | 71.4% | 0.8 | 0.8 | 63.7 |
| 2023-2025  | -58.0% | 72.1% | 1.2 | 1.2 | 59.9 |

The table shows fluctuating performance, with periods of significant outperformance (high Alpha) and periods of underperformance or market tracking (low Alpha).  The Beta also fluctuates, suggesting varying levels of sensitivity to overall market movements.


**2. Recent Price Movement:**

* **Closing Price:** $269.01
* **5-Day Moving Average:** $261.79
* **20-Day Moving Average:** $282.73
* **60-Day Moving Average:** $303.66

The closing price is below all three moving averages, suggesting a downward trend.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.47 (High Risk)
* **RSI:** 37.80 (Approaching oversold territory, but not definitively so)
* **PPO:** -0.69 (Negative, indicating bearish momentum)
* **Recent Relative Divergence:** -6.9% (Short-term downtrend)
* **Expected Return:** -30.6% (This suggests significant underperformance relative to the S&P 500 over the long term (2+ years) based on current conditions).  This must be considered cautiously as expected returns are estimates subject to inherent uncertainty. The positive price change in `Last-market` suggests a slight rebound, mitigating the extreme bearishness implied by other indicators.

The indicators paint a mixed picture.  While some point towards potential oversold conditions, others highlight negative momentum and a high risk profile.  The price increase of $2.66 compared to the previous close needs to be evaluated within the context of the longer-term downtrend and other bearish signals.  This could represent a temporary bounce or the beginning of a reversal, but more data is needed for a confident assessment.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2025-02-06 | 2.77 | $2.93B       |
| 2024-08-01 | 3.13 | $2.99B       |
| 2024-04-30 | 2.57 | $2.93B       |
| 2024-02-05 | 2.74 | $3.00B       |
| 2025-02-06 | 2.74 | $3.00B       |

There's some inconsistency in the provided data.  There are two entries for 2025-02-06 with slightly different EPS and Revenue figures.  The revenue is relatively stable, while EPS fluctuates, suggesting potential volatility in profitability. More data or clarification is needed for a thorough analysis.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.93B | 31.21% |
| 2024-09-30 | $3.19B | 33.98% |
| 2024-06-30 | $2.99B | 32.82% |
| 2024-03-31 | $2.93B | 32.04% |
| 2023-12-31 | $3.00B | 31.03% |

Revenue shows some fluctuations, but generally remains stable around $3 billion.  Profit margins are consistently high, ranging from 31% to 34%.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $16.69B | 3.70% |
| 2024-09-30 | $17.04B | 11.45% |
| 2024-06-30 | $15.10B | 4.61% |
| 2024-03-31 | $14.91B | 3.84% |
| 2023-12-31 | $14.87B | 4.10% |

Equity and ROE show more variability.  While equity generally increases, ROE fluctuates significantly, suggesting potential factors influencing profitability.


**6. Overall Analysis:**

APD's recent performance has underperformed the S&P 500 significantly. While it boasts strong historical periods of growth and high profit margins, recent data reveals a bearish trend, reflected in negative PPO, relatively low RSI, and a negative expected return relative to the market.  The short-term price increase might indicate a temporary bounce.  However, the substantial negative divergence from the S&P 500 and other technical indicators raise concerns.  Further investigation is required to understand the reasons behind the underperformance and to assess the long-term prospects of APD.  The inconsistencies in the earnings data require clarification. A thorough evaluation of the company's strategy, industry dynamics, and competitive landscape is crucial before making any investment decisions.  The high-risk profile identified by the MRI adds to the overall cautionary note.
